Cardiovascular Diabetology

1. Cardiovasc Diabetol26 Mar 2025

   Association between C-reactive protein-triglyceride glucose index and stroke risk in different glycemic status: insights from the China Health and Retirement Longitudinal Study (CHARLS)

   Cohort studyT2D & other

2. Cardiovasc Diabetol26 Mar 2025

   Cardiovascular abnormalities already occurred in newly-diagnosed patients with early-onset type 2 diabetes

   Cohort studyT2D & other

3. Cardiovasc Diabetol24 Mar 2025

   Association between triglyceride–glucose index and mortality in critically ill patients with atrial fibrillation: a retrospective cohort study

   Cohort studyT2D & other

4. Cardiovasc Diabetol24 Mar 2025

   The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0–3 of cardiovascular–kidney–metabolic syndrome: evidence from two cohort studies

   Cohort studyT2D & other

5. Cardiovasc Diabetol22 Mar 2025

   Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial

   Secondary analysisT2D & other

6. Cardiovasc Diabetol22 Mar 2025

   Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction

   Cohort studyComplications

7. Cardiovasc Diabetol22 Mar 2025

   Impact of glycemic control metrics on short- and long-term mortality in transcatheter aortic valve replacement patients: a retrospective cohort study from the MIMIC-IV database

   Cohort studyT2D & other

8. Cardiovasc Diabetol21 Mar 2025

   The impact of hypercortisolism beyond metabolic syndrome on left ventricular performance: a myocardial work analysis

   Cross-sectional studyAdrenal

9. Cardiovasc Diabetol21 Mar 2025

   Association of triglyceride-glucose index trajectories with the risk of worsening heart failure in elderly patients with chronic heart failure and type 2 diabetes: a competing risk analysis

   Cohort studyT2D & other

10. Cardiovasc Diabetol21 Mar 2025

    Accelerometer-derived “weekend warrior” physical activity pattern and incident type 2 diabetes

    Cohort studyT2D & other

11. Cardiovasc Diabetol21 Mar 2025

    Association between triglyceride glucose-body mass index and the trajectory of cardio-renal-metabolic multimorbidity: insights from multi-state modelling

    Cohort studyT2D & other

12. Cardiovasc Diabetol20 Mar 2025

    Dysglycaemia is associated with the pattern of valvular calcification in micro-computed tomography analysis: an observational study in patients with severe aortic stenosis

    Case-control studyT2D & other

13. Cardiovasc Diabetol20 Mar 2025

    The adverse effect of metabolic syndrome on left ventricular global strains and myocardial energetic efficiency in non-ischemic dilated cardiomyopathy patients: a cardiac magnetic resonance study

    Cross-sectional study

14. Cardiovasc Diabetol20 Mar 2025

    Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation

    Cross-sectional studyLipids & liver

15. Cardiovasc Diabetol20 Mar 2025

    Metabolomic profiling reveals early biomarkers of gestational diabetes mellitus and associated hepatic steatosis

    Case-control studyDiabetes in pregnancy

16. Cardiovasc Diabetol19 Mar 2025

    Association of atherogenic index of plasma trajectory with the incidence of cardiovascular disease over a 12-year follow-up: findings from the ELSA cohort study

    Cohort study

17. Cardiovasc Diabetol17 Mar 2025

    Higher hemoglobin levels are associated with impaired left ventricular global strains in metabolic syndrome: a 3.0 T CMR feature tracking study

    Cross-sectional study

18. Cardiovasc Diabetol14 Mar 2025

    Proteomic signatures of type 2 diabetes predict the incidence of coronary heart disease

    Cohort studyT2D & other

19. Cardiovasc Diabetol12 Mar 2025

    Cardiometabolic risk factors and disease trends for atrial fibrillation in individuals with type 1 diabetes: a nationwide registry study

    Cohort studyT1D

20. Cardiovasc Diabetol12 Mar 2025

    Association between the triglyceride glucose-Chinese visceral adiposity index and new-onset stroke risk: a national cohort study

    Cohort studyT2D & other

21. Cardiovasc Diabetol10 Mar 2025

    Cholesterol, high-density lipoprotein, and glucose index versus triglyceride–glucose index in predicting cardiovascular disease risk: a cohort study

    Cohort studyLipids & liver

22. Cardiovasc Diabetol10 Mar 2025

    Additive association of blood group A allele with 15 cardiometabolic diseases: a UK Biobank life-course study

    Cohort studyLipids & liver

23. Cardiovasc Diabetol10 Mar 2025

    Triglyceride glucose index predicts long-term mortality and major adverse cardiovascular events in patients with type 2 diabetes

    Cohort studyT2D & other

24. Cardiovasc Diabetol10 Mar 2025

    Can cardiovascular health and its modifiable healthy lifestyle offset the increased risk of all-cause and cardiovascular deaths associated with insulin resistance?

    Cohort studyT2D & other

25. Cardiovasc Diabetol10 Mar 2025

    Assessing the impact of insulin resistance trajectories on cardiovascular disease risk using longitudinal targeted maximum likelihood estimation

    Cohort study

26. Cardiovasc Diabetol8 Mar 2025

    Echocardiographic and biomarker characteristics in diabetes, coronary artery disease or both: insights from HOMAGE trial

    Secondary analysisT2D & other

27. Cardiovasc Diabetol8 Mar 2025

    Joint assessment of abdominal obesity and non-traditional lipid parameters for primary prevention of cardiometabolic multimorbidity: insights from the China health and retirement longitudinal study 2011–2018

    Cohort studyObesity

28. Cardiovasc Diabetol8 Mar 2025

    Triglyceride-glucose index correlates with the incidences and prognoses of cardiac arrest following acute myocardial infarction: data from two large-scale cohorts

    Cohort study

29. Cardiovasc Diabetol5 Mar 2025

    A one-week reduced-carbohydrate diet to mitigate iatrogenic peripheral hyperinsulinemia does not improve insulin sensitivity or endothelial function in a randomized, crossover trial in patients with type 1 diabetes

    Randomized controlled trialT1D

30. Cardiovasc Diabetol5 Mar 2025

    Long-term trajectory of estimated glomerular filtration rate in ambulatory patients with type 2 diabetes and heart failure: clinical insights and prognostic implications

    Secondary analysisComplications

31. Cardiovasc Diabetol5 Mar 2025

    Atherogenic index of plasma, high sensitivity C-reactive protein and incident diabetes among middle-aged and elderly adults in China: a national cohort study

    Cohort studyT2D & other

32. Cardiovasc Diabetol5 Mar 2025

    Circulating mitochondrial DNA signature in cardiometabolic patients

    Cross-sectional studyT2D & other

33. Cardiovasc Diabetol5 Mar 2025

    Aortic valve calcification across stages of dysglycemia in middle-aged individuals from the general population

    Cross-sectional studyT2D & other

34. Cardiovasc Diabetol1 Mar 2025

    Associations of triglyceride glucose-body mass index and the combination of sedentary behavior and physical activity with risks of all-cause mortality and myocardial infarction: a cohort study from the UK biobank

    Cohort study

35. Cardiovasc Diabetol28 Feb 2025

    Comparison of triglyceride glucose index and modified triglyceride glucose indices in predicting cardiovascular diseases incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0–3: a nationwide prospective cohort study

    Cohort studyT2D & other

36. Cardiovasc Diabetol28 Feb 2025

    The impact of metformin on kidney disease progression and mortality in diabetic patients using SGLT2 inhibitors: a real-world cohort study

    Cohort studyT2D & other

37. Cardiovasc Diabetol28 Feb 2025

    Lipid-lowering therapy and LDL target attainment in type 2 diabetes: trends from the Italian Associations of Medical Diabetologists database

    Cross-sectional studyT2D & other

38. Cardiovasc Diabetol28 Feb 2025

    Association between triglyceride glucose index and biological aging in U.S. adults: National Health and Nutrition Examination Survey

    Cross-sectional studyT2D & other

39. Cardiovasc Diabetol28 Feb 2025

    Comprehensive evaluation of diabetes subtypes in a European cohort reveals stronger differences of lifestyle, education and psychosocial parameters compared to metabolic or inflammatory factors

    Cross-sectional studyT2D & other

40. Cardiovasc Diabetol28 Feb 2025

    Relationship between atherogenic index of plasma and length of stay in critically ill patients with atherosclerotic cardiovascular disease: a retrospective cohort study and predictive modeling based on machine learning

    Cohort studyLipids & liver

All 1,291 Briefs in ExploreShowing Briefs 521–560 of 1,291, newest first